Apple (AAPL 0.47%) just wrapped up a jam-packed three days of new product releases. While the launch of a $599 entry-level laptop dubbed the MacBook Neo garnered headlines for its affordability, there's something bigger at play -- something that keeps resurfacing across almost all of its product announcements: artificial intelligence (AI). Apple is aggressively outfitting its professional and consumer product stack to run heavy artificial intelligence workloads -- and it isn't being shy about trying to draw attention to this push.
Ultimately, Apple is tapping into a major selling point as it releases new products, highlighting that its latest products aren't just incremental upgrades but part of a major hardware transformation -- a transformation that could help accelerate sales.
Apple's new Neo MacBook. Image source: Apple.
Silicon built for heavy AI workloads At the core of this three-day product launch event is the revamped MacBook Pro lineup, powered by the new M5 Pro and M5 Max architectures. Management noted in the press release that the new silicon features up to four times the AI performance of the previous MacBook Pro generation and up to eight times the AI performance of M1-powered models.
"With Neural Accelerators in the GPU, the new MacBook Pro enables professionals to run advanced [large language models] on device and unlock capabilities that no other laptop can do," said Apple hardware engineering chief John Ternus in the company's press release about the new 14- and 16-inch laptops.
This AI theme was present in the product release for every new Apple product announced this week, except its new monitors.
Even the new entry-level MacBook Neo features a dedicated 16-core neural engine that "supports fast on-device Apple Intelligence features and everyday AI tasks," the company said.
By embedding powerful local processing across its entire lineup, Apple is not only giving customers a reason to upgrade, but it's quietly ensuring its hardware base is ready before it unveils a heavily overhauled, smarter version of Siri later this year.
Supercharging an already massive hardware cycle This push for artificial intelligence hardware comes at a time of impressive momentum for Apple.
The company's fiscal 2026 first-quarter revenue surged 16% year over year to a record $143.8 billion -- an acceleration from 8% growth in the fourth quarter of fiscal 2025. That impressive top-line acceleration was driven largely by the iPhone. Fiscal first-quarter iPhone revenue spiked 23% year over year to $85.3 billion.
The influx of highly capable, artificial intelligence-ready iPads and Macs announced this week -- not to mention the new, aggressively priced iPhone 17e -- could easily compound this momentum, given their appeal in an increasingly AI-first technological environment. And keep in mind that Apple boasts an installed base of more than 2.5 billion active devices. A bigger-than-usual upgrade cycle, therefore, could have a significant impact on the tech giant's financials.
And while hardware drives the headlines, these device sales ultimately feed Apple's highly lucrative Services segment, which commands a gross margin typically hovering around 75%. So the true value of these devices to Apple (and shareholders) is far greater than their sale price.
Today's Change
(
-0.47
%) $
-1.23
Current Price
$
262.52
But is all of this excitement already priced into the stock?
With a market capitalization of about $3.9 trillion as of this writing and a price-to-earnings ratio of about 34, the stock commands a premium valuation. But I think Apple is one of those rare companies worth paying a premium for -- especially ahead of what could be a multi-year upgrade supercycle driven by artificial intelligence; Apple's AI-focused hardware will likely play an increasingly important role in both consumers' and professionals' daily tasks, leading to a big wave of upgrades.
Of course, investors should keep an eye on key risks, including supply chain risks stemming from Apple's global supply chain, surging memory prices, and regulatory scrutiny given Apple's massive scale. Overall, however, I think Apple stock is worth paying up for as consumers and businesses increasingly look to upgrade their devices to be better equipped for an era of accelerating technological transformation.
2026-03-05 03:017d ago
2026-03-04 21:327d ago
KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Kyndryl Holdings, Inc. (NYSE: KD) between August 7, 2024 and February 9, 2026, both dates inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
So what: If you purchased Kyndryl securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Kyndryl class action, go to https://rosenlegal.com/submit-form/?case_id=38139 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 13, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Kyndryl's financial statements issued during the Class Period were materially misstated; (2) Kyndryl lacked adequate internal controls and at times materially understated issues with its internal controls; (3) as a result, Kyndryl would be unable to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025; and (4) as a result, defendants' statements about Kyndryl's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Kyndryl class action, go to https://rosenlegal.com/submit-form/?case_id=38139 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
2026-03-05 03:017d ago
2026-03-04 21:327d ago
Roku, Inc. (ROKU) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Roku, Inc. (ROKU) Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 4:05 PM EST
Company Participants
Anthony Wood - Founder, Chairman, President & CEO
Presentation
Unknown Analyst
All right. We're going to get started here. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I am very pleased to welcome Anthony Wood, Founder and CEO of Roku. Thank you so much for coming back to the conference.
Anthony Wood
Founder, Chairman, President & CEO
Thanks for having me. I appreciate it.
Question-and-Answer Session
Unknown Analyst
All right. So you looked -- you reported a couple of weeks ago, and you talked about a 2026 outlook that gave investors, I think, a little bit of a peek into what you see as a potential growth opportunity going forward. As we look out to this year, what do you think are the 2 or 3 biggest strategic priorities for you, for the company? And what do you think will be most different about your business if all goes well and you execute on your plan?
Anthony Wood
Founder, Chairman, President & CEO
Yes. So our priorities are really to focus on our main businesses. So our main businesses are advertising and subscriptions. And then I would say the third priority would be our home screen. So I'll just talk a little bit about each of those. So advertising is doing really well for us. It's been a very positive business. It's growing nicely.
And in advertising, we're focused on being the most performant connected TV platform, so continuing to invest in integrating generative AI throughout our platform to drive even more performance on our platform, integrating with DSPs. So a big
2026-03-05 03:017d ago
2026-03-04 21:347d ago
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
NEW ORLEANS, March 04, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics Incorporated (NasdaqCM: CORT) (“Corcept” or the “Company”), if they purchased or otherwise acquired the Company’s shares between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
Get Help
Corcept investors should visit us at https://claimsfiler.com/cases/nasdaq-cort-1/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Corcept and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The complaint alleges that, during the Class Period, the Company represented to investors that there was a high likelihood that one of its lead new product candidates, relacorilant, would receive approval from the U.S. Food and Drug Administration (“FDA”) after the Company’s New Drug Application (“NDA”) submission. However, on December 31, 2025, the Company disclosed that the FDA had issued a Complete Response Letter (“CRL”) regarding the NDA for relacorilant and that it had “concluded it could not arrive at a favorable benefit-risk assessment for relacorilant without Corcept providing additional evidence of effectiveness.”
On this news, the price of Corcept’s shares plummeted by $35.40 per share, or 50.4%, from a closing price of $70.20 on December 30, 2025, to a closing price of $34.80 on December 31, 2025.
The case is Allegheny County Employees’ Retirement System v. Corcept Therapeutics Incorporated, No. 26-cv-01525.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
2026-03-05 03:017d ago
2026-03-04 21:357d ago
Navan Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Navan, Inc. - NAVN
NEW ORLEANS, March 04, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 24, 2026 to file lead plaintiff applications in a securities class action lawsuit against Navan, Inc. (“Navan” or the “Company”) (NasdaqGS: NAVN), if they purchased or otherwise acquired the Company’s shares pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with Navan’s October 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Northern District of California.
Get Help
Navan investors should visit us at https://claimsfiler.com/cases/nasdaq-navn/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Navan and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that the Company had increased its “sales and marketing” expenses for the quarter ending October 31, 2025 to nearly $95 million, or by 39% compared to $68.5 million sales and marketing expenses in the quarter ending July 31, 2025. When the true details entered the market, the lawsuit claims that the Company’s shares fell sharply.
The case is McCown v. Navan, Inc., Case No. 26-cv-01550.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
2026-03-05 03:017d ago
2026-03-04 21:377d ago
ROSEN, A LEADING LAW FIRM, Encourages Paysafe Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – PSFE
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Paysafe Limited (NYSE: PSFE) between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”), of the important April 7, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Paysafe securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Paysafe class action, go to https://rosenlegal.com/submit-form/?case_id=2745 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Paysafe’s ecommerce business had significant exposure to a single high risk client; (2) as a result, Paysafe’s credit loss reserves and/or write-offs were understated; (3) Paysafe had an undisclosed issue with higher risk Merchant Category Codes, making its client services difficult to bank; (4) the foregoing issues were likely to have a material negative impact on Paysafe’s revenue growth and overall revenue mix; (5) as a result, Paysafe was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (6) as a result of the foregoing, defendants’ positive statements about Paysafe’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Paysafe class action, go to https://rosenlegal.com/submit-form/?case_id=2745 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
2026-03-05 03:017d ago
2026-03-04 21:397d ago
Kyndryl Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Kyndryl Holdings, Inc. - KD
NEW ORLEANS, March 04, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD), if they purchased or otherwise acquired the Company’s shares between August 7, 2024 and February 9, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Kyndryl investors should visit us at https://claimsfiler.com/cases/nyse-kd/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Kyndryl and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 9, 2026, the Company disclosed that it would be unable to timely file its Form 10-Q Report for the quarter ended December 31, 2025 and that “the Company anticipates reporting material weaknesses in the Company’s internal control over financial reporting for the period covered in the Quarterly Report, as well as for the full fiscal year ended March 31, 2025, and the first two fiscal quarters of fiscal year 2026, which are expected to include, but may not be limited to, the effectiveness and strength of certain functions at the Company, including with respect to controls related to information and communication and tone at the top,” as well as the departure of its C.F.O and General Counsel. On this news, the price of Kyndryl’s shares fell $12.90 per share, or 55%, to close at $10.59 on February 9, 2026.
The case is Brander v. Kyndryl Holdings, Inc., et al., No. 26-cv-00782.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
2026-03-05 03:017d ago
2026-03-04 21:397d ago
Enphase Energy Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Enphase Energy, Inc. - ENPH
NEW ORLEANS, March 04, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Enphase Energy, Inc. (“Enphase” or the “Company”) (NasdaqGM: ENPH), if they purchased or otherwise acquired the Company’s securities between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
Get Help
Enphase Energy investors should visit us at https://claimsfiler.com/cases/nasdaq-enph-3/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Enphase Energy and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company had overstated its ability to manage its channel inventory; (ii) the Company had overstated its ability to offset the impacts resulting from the termination of the Residential Clean Energy Credit pursuant to Internal Revenue Code Section 25D; and (iii) as a result, the Company overstated its financial and operational prospects.
The case is Tripathi v. Enphase Energy, Inc., No. 26-cv-01380.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
2026-03-05 03:017d ago
2026-03-04 21:407d ago
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
New York, New York--(Newsfile Corp. - March 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Ultragenyx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Ultragenyx class action, go to https://rosenlegal.com/submit-form/?case_id=52472 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 6, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants provided investors with material information concerning Ultragenyx's expected results for its Phase III Orbit and Cosmic Studies, which tested setrusumab (UX 143) in patients with Osteogenesis Imperfecta ("OI"). Defendants' statements included, among other things, confidence in setrusumab's ability to ultimately trigger a decrease in the OI patients' annualized fracture rate, alongside confidence in the study designs to demonstrate such ability and reduce testing variability that could interfere with such a result.
The lawsuit claims that defendants provided these overwhelmingly positive statements to investors while simultaneously disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of setrusumab's potential, as well as the true risk inherent in the study protocols put forth; notably, that while setrusumab does increase material bone density, this increase does not correlate to a decrease in annualized fracture rates or otherwise, that the Phase III Orbit and Cosmic studies were much less likely to be able to demonstrate such a link than management claimed. The lawsuit claims that such statements absent these material facts caused Ultragenyx shareholders to purchase Ultragenyx securities at artificially inflated prices. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Ultragenyx class action, go to https://rosenlegal.com/submit-form/?case_id=52472 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286339
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-05 03:017d ago
2026-03-04 21:407d ago
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
NEW ORLEANS, March 04, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against uniQure N.V. (NasdaqGS: QURE) (“uniQure” or the “Company”), if they purchased or otherwise acquired the Company’s shares between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Get Help
uniQure investors should visit us at https://claimsfiler.com/cases/nasdaq-qure/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
uniQure and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
During the Class Period, the Company represented to investors that there was a high likelihood that its leading drug candidate, AMT-130, would receive accelerated approval from the U.S. Food and Drug Administration (“FDA”) after the Company’s planned Biologics License Application (“BLA”) submission in the first quarter of 2026. However, on November 3, 2025, the Company disclosed that “the FDA currently no longer agrees that the data from the Phase I/II studies of AMT-130 in comparison to an external control, as per the prespecified protocols and statistical analysis plans shared with the FDA in advance of the analyses, may be adequate to provide the primary evidence in support of a BLA submission” and as a result, “the timing of the BLA submission for AMT-130 is now unclear.”
On this news, the price of uniQure’s shares plummeted $33.40 per share, or more than 49%, from a close of $67.69 per share on October 31, 2025, to close at $34.29 per share on November 3, 2025.
The case is Scocco v. uniQure N.V., et al., Case No. 1:26-cv-01124.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
2026-03-05 03:017d ago
2026-03-04 21:437d ago
BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Beyond Meat, Inc. (NASDAQ: BYND) between February 27, 2025 and November 11, 2025, both dates inclusive (the "Class Period"), of the important March 24, 2026 lead plaintiff deadline.
So what: If you purchased Beyond Meat securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Beyond Meat class action, go to https://rosenlegal.com/submit-form/?case_id=16090 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the book value of certain of Beyond Meat's long-lived assets exceeded their fair value, making it highly likely that Beyond Meat would be required to record a material, non-cash impairment charge; (2) the foregoing was likely to impair Beyond Meat's ability to timely file its periodic filings with the Securities and Exchange Commission; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Beyond Meat class action, go to https://rosenlegal.com/submit-form/?case_id=16090 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
2026-03-05 03:017d ago
2026-03-04 21:437d ago
TSLY: Tesla's Uncertainty Is Fueling This Income Machine
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-03-05 03:017d ago
2026-03-04 21:477d ago
ROSEN, A LONGSTANDING FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”), of the important April 13, 2026 lead plaintiff deadline.
SO WHAT: If you purchased uniQure ordinary shares during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the uniQure class action, go to https://rosenlegal.com/submit-form/?case_id=53025 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 13, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants misrepresented and/or failed to disclose that: (1) the design of uniQure’s Pivotal Study (a study of uniQure’s leading drug candidate in patients with Huntington’s Disease) — including comparison of the Pivotal Study results to the ENROLL-HD external historical data set— was not fully approved by the U.S. Food and Drug Administration (the “FDA”); (2) defendants downplayed the likelihood that, despite purportedly highly successful results from the Pivotal Study, uniQure would have to delay its Biologics License Application (“BLA”) timeline to perform additional studies to supplement its BLA submission; and (3) as a result, defendants’ statements about uniQure’s business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the uniQure class action, go to https://rosenlegal.com/submit-form/?case_id=53025 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
2026-03-05 03:017d ago
2026-03-04 21:487d ago
EOSE Investors Have Opportunity to Join Eos Energy Enterprises, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $EOSE--EOSE Investors Have Opportunity to Join Eos Energy Enterprises, Inc. Fraud Investigation with the Schall Law Firm.
2026-03-05 03:017d ago
2026-03-04 21:507d ago
Apollo Global Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Apollo Global Management, Inc. - APO
NEW ORLEANS, March 04, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 1, 2026 to file lead plaintiff applications in a securities class action lawsuit against Apollo Global Management, Inc. (NYSE: APO) (“Apollo” or the “Company”), if they purchased or otherwise acquired the Company’s securities between May 10, 2021 and February 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Get Help
Apollo investors should visit us at https://claimsfiler.com/cases/nyse-apo/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Apollo and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company’s leadership figures, including defendants Marc Rowan and Leon Black, frequently communicated with Jeffrey Epstein in the 2010s regarding the Company’s business; (ii) as a result, the Company’s assertion that Apollo Global had never done business with Jeffrey Epstein was untrue; (iii) because of the entanglement between Apollo Global’s leaders and Jeffrey Epstein, the harm to the Company’s reputation was more than a mere possibility; and (iv) as a result, the Company’s statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.
The case is Feldman v. Apollo Global Management, Inc., et al., Case No. 26-cv-01692.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
2026-03-05 03:017d ago
2026-03-04 21:527d ago
Walmart Inc. (WMT) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Flutter Entertainment plc (PDYPY) Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 5:35 PM EST
Company Participants
Jeremy Jackson - CEO & Executive Director
Rob Coldrake - Chief Financial Officer
Conference Call Participants
Edward Young - Morgan Stanley, Research Division
Presentation
Edward Young
Morgan Stanley, Research Division
So hello. I'm delighted to be joined by Peter Jackson and Rob Coldrake, from Flutter. Thanks very much for joining us again at the conference.
Jeremy Jackson
CEO & Executive Director
Thank you very much for having us.
Question-and-Answer Session
Edward Young
Morgan Stanley, Research Division
So you reported results last week. Revenue was up 17%, EBITDA was up 21%. But obviously, an awful lot of drivers within the business. So perhaps for ease, we'll start with the U.S., as you probably expect me to say. So I guess as a sort of short overview at the start what did you make of the U.S. performance in '25?
Jeremy Jackson
CEO & Executive Director
Yes. well thank you, Ed. I mean hopefully, we'll get to speak about international...
Edward Young
Morgan Stanley, Research Division
You will.
Jeremy Jackson
CEO & Executive Director
As that is an important part of the business. But from a U.S. perspective, I think that -- look, let's start with the most successful part of our business, which is the iGaming business. We exited Q4 with 28% of GGR. I think our strategy of building exclusive content, having access to the loyalty program has been working really effectively for us. We're excited with the way that the business exited last year and the prospects for it through the course of this year.
If I take our sports business, I have no doubt we'll talk about Q4 at some stage. Actually, the progress we're making in terms of getting towards our
2026-03-05 03:017d ago
2026-03-04 21:577d ago
South L.A. Residents Gain 37 New Affordable Homes as Eleos and Health Net Break Ground at 5637 S. Broadway
New development adds long-term housing stability for low-income households in South Los Angeles
, /PRNewswire/ -- More South Los Angeles residents will soon have a stable place to call home. Today, Eleos and Health Net marked the start of construction on a new 37-unit affordable housing community at 5637 S. Broadway in South Los Angeles.
Eleos Logo
Top left image, from left to right: Mary Abad, Self Help Venture Fund; Isela Gracian, Office of Supervisor Holly Mitchell; Claudia Monterrosa, Office of Mayor Karen Bass; David Aghaei, Eleos; Dorothy Seleski, Health Net; Ambar Quintanilla, Office of Senator Lola Smallwood Cuevas; Daniel Dayan, Eleos; Joe Iniguez, HTA Construction The project was made possible in part by a $550K investment from Health Net, which helped close the remaining funding gap and advance construction of the 100% affordable development. This is a 100% affordable development — all 37 homes are income-restricted and intended for households with low incomes, rather than a mix of market-rate and affordable units. Community leaders and partners gathered at the site to recognize what this project will deliver for the neighborhood: more housing stability, fewer families priced out of the community, and a clearer path to long-term well-being.
"This project reflects what we're working toward at Eleos: delivering high-quality affordable housing faster, more efficiently, and through meaningful partnerships," said David Aghaei, co-founder and principal of Eleos. "By combining private financing, streamlined policy and philanthropic support, we're showing it's possible to move projects forward without delay and without compromising on quality."
"Congratulations to Eleos Ventures on breaking ground on 37-new homes in our South Los Angeles community," said Los Angeles County Supervisor Holly J. Mitchell. "Eleos and Health Net are showing what's possible with public and private partnerships, together putting residents first. These 37 new homes will strengthen this corridor, improve health outcomes, and help families build a more secure future right here in South L.A."
Faster approvals — without waiting years to start building
The South Broadway development received entitlements and permits in nine months under Mayor Karen Bass' Executive Directive 1; the City's streamlined approval pathway designed to accelerate housing. Unlike many affordable housing developments, the project is privately financed and delivered without public subsidy, applying discipline, speed and cost efficiency to housing residents with the greatest need.
"Too many families are priced out of safe, stable housing — even when they're working full time and doing everything right," said Daniel Dayan, co-founder and principal of Eleos. "This development reflects our commitment to closing that gap and creating homes that strengthen neighborhoods and support long-term stability."
Health Net partnership helps close the gap
The project was supported in part by Health Net, whose grant helped close the remaining funding gap and expand access for residents with the greatest need. Since 2020, Health Net has committed $93 million to housing and homelessness initiatives across California, advancing long‑term stability and improved health outcomes for communities most in need.
"Safe, stable housing changes everything — it improves health, strengthens job stability and protects childhoods," said Dorothy Seleski, Medi-Cal President at Health Net. "We're proud to partner with Eleos to bring affordable homes to South Los Angeles, because when families have a secure place to live, they can focus on getting healthier, working to provide for their families and staying rooted in their neighborhood. Our grant helped close the final funding gap so this community can move from uncertainty to stability, and we'll continue investing in practical solutions that give residents real opportunity for long-term well-being."
Eleos will serve as both the developer and operator of the South Broadway community. Across Los Angeles, Eleos has more than 1,300 housing units completed, under construction, or in its active pipeline. Eleos also works with nonprofit service providers and public agencies to support successful lease-up and long-term stability. Many Eleos properties serve residents who have experienced homelessness, rely on housing vouchers, or fall within the "missing middle" income range that often lacks access to traditional subsidies.
What's next
Construction is now underway, with completion anticipated in summer or fall of 2027.
About Health Net
Founded in California more than 45 years ago, Health Net, LLC ("Health Net"), a company of Centene Corporation, believes that every person deserves a safety net for their health, regardless of age, income, employment status or current state of health. Today, we provide health plans for individuals, families, businesses of every size and people who qualify for Medi-Cal or Medicare. With more than 117,000 of our network providers, Health Net serves more than three million members across the state. We also offer access to substance abuse programs, behavioral health services and managed healthcare products related to prescription drugs. We make these health plans and services available through Health Net and its subsidiaries: Health Net of California, Inc., Health Net Life Insurance Company and Health Net Community Solutions, Inc. These entities are wholly owned subsidiaries of Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to transforming the health of the communities we serve, one person at a time. Health Net and Centene Corporation employ more than 5,700 people in California who work at one of five regional Talent Hub offices. For more information, visit www.HealthNet.com.
About Eleos
Eleos was founded with one goal in mind –– to change the space that people live, work and play in for the better. And all of this was fueled by the housing crisis in Los Angeles, which brought to bear the dire need for affordable solutions for our fellow residents who are seemingly forgotten by the current market-rate housing mix. Eleos regularly works with institutions to apply its expertise and resources to a new model of privately funded affordable housing solutions that drive lasting, permanent change. For additional information about Eleos, visit https://www.eleos.la/.
SOURCE Health Net
2026-03-05 02:017d ago
2026-03-04 20:087d ago
Jensen Huang says Nvidia is pulling back from OpenAI and Anthropic, but his explanation raises more questions than it answers
At the Morgan Stanley Technology, Media and Telecom conference in downtown San Francisco Wednesday, Nvidia CEO Jensen Huang said his company’s recent investments in OpenAI and Anthropic are likely to be its last in both, saying that once they go public as anticipated later this year, the opportunity to invest closes.
It could be that simple. While firms sometimes pile into companies until practically the eve of their public debut in search of more upside, Nvidia is minting money selling the chips that power both companies — it’s not like it needs to goose its returns by pouring even more money into either one.
Nvidia, for its part, isn’t offering much elaboration. Asked for comment earlier today following Huang’s remarks, a spokesman pointed TechCrunch to a transcript from the company’s fourth-quarter earnings call, where Huang said all of Nvidia’s investments are “focused very squarely, strategically on expanding and deepening our ecosystem reach,” a goal its earlier stakes in both companies have arguably met.
Still, a few other dynamics might also explain the pullback, including the circular nature of these arrangements themselves, which have raised questions about a potential bubble. When Nvidia first announced it would invest up to $100 billion in OpenAI last September, MIT Sloan professor Michael Cusumano blandly described it to the Financial Times as “kind of a wash,” observing that “Nvidia is investing $100 billion in OpenAI stock, and OpenAI is saying they are going to buy $100 billion or more of Nvidia chips.”
The commitment shrank either way. The investment Nvidia finalized just last week as part of OpenAI’s $110 billion round came in at $30 billion — well short of the $100 billion it had once pledged. Meanwhile, Huang has dismissed suggestions of bad blood between the two companies as “nonsense,” though Nvidia’s relationship with Anthropic has looked fraught in its own right.
Just two months after Nvidia announced a $10 billion investment in November, Anthropic CEO Dario Amodei took the stage at Davos and, without naming Nvidia directly, compared the act of U.S. chip companies selling high-performance AI processors to approved Chinese customers to “selling nuclear weapons to North Korea.” (Ouch.)
In retrospect, a nuclear weapons comparison was the least of it. Just days before Huang appeared at the banking conference, the Trump administration blacklisted Anthropic, barring federal agencies and military contractors from using its tech after the company refused to allow its models to be used for autonomous weapons or mass domestic surveillance.
Techcrunch event
San Francisco, CA | October 13-15, 2026
Within hours of that announcement, OpenAI struck its own deal with the Pentagon — a move Anthropic has called “mendacious” and the public appears to have viewed similarly. Within 24 hours, Claude had shot to the top of Apple’s U.S. App Store, overtaking ChatGPT. (At the end of January, Anthropic was outside the top 100, according to Sensor Tower data.)
Where that leaves Nvidia is holding stakes in two companies that, at this particular moment, are pulling in very different directions — one newly aligned with the Defense Department, and the other blacklisted by it.
Whether Huang saw any of this coming, given Nvidia’s web of partnerships, is impossible to know. But his stated reason on Wednesday for likely pulling the plug on future investments — that the IPO window closes the door on this kind of deal — is hard to square with how late-stage private investing actually works. What’s looking more probable s that this is an exit from a situation that has gotten really complicated, really fast.
Loizos has been reporting on Silicon Valley since the late ’90s, when she joined the original Red Herring magazine. Previously the Silicon Valley Editor of TechCrunch, she was named Editor in Chief and General Manager of TechCrunch in September 2023. She’s also the founder of StrictlyVC, a daily e-newsletter and lecture series acquired by Yahoo in August 2023 and now operated as a sub brand of TechCrunch.
You can contact or verify outreach from Connie by emailing [email protected] or [email protected], or via encrypted message at ConnieLoizos.53 on Signal.
2026-03-05 02:017d ago
2026-03-04 20:107d ago
Barclays: The Market Overheated, But The Bull Case Now Offers Strong Returns
Analyst’s Disclosure: I/we have a beneficial long position in the shares of BCS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This writing is for informational purposes only. All opinions expressed herein are not investment recommendations, and are not meant to be relied upon in investment decisions. The author is not acting in an investment advisor capacity and is not a registered investment advisor. The author recommends investors consult a qualified investment advisor before making any trade. This article is not an investment research report, but an opinion written at a point in time. The author's opinions expressed herein address only a small cross-section of data related to an investment in securities mentioned. Any analysis presented is based on incomplete information, and is limited in scope and accuracy. The information and data in this article are obtained from sources believed to be reliable, but their accuracy and completeness are not guaranteed. Any and all opinions, estimates, and conclusions are based on the author's best judgment at the time of publication, and are subject to change without notice. Past performance is no guarantee of future returns.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
VANCOUVER, BC / ACCESS Newswire / March 4, 2026 / Global Education Communities Corp. ("GECC" or the "Company") (TSX:GEC)(OTCQB:GECSF) has completed the divestment of its remaining Canadian educational assets as of February 28, 2026. This final sale marks the Company's strategic evolution into a pure-play student housing developer and operator, centred on a project pipeline currently valued at approximately $674 million (based on construction budgets), in addition to eight operational properties across Metro Vancouver.
2026-03-05 02:017d ago
2026-03-04 20:157d ago
Oil Rises on Prospects of Prolonged Supply Disruptions
Investing in the private credit market can offer high yields, but the downside risks are real and increasingly visible.
2026-03-05 02:017d ago
2026-03-04 20:167d ago
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding the Upcoming March 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vistagen (VTGN) To Contact Him Directly To Discuss Their Options
If you purchased or acquired Vistagen common stock between April 1, 2024 and December 16, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN) in the U.S. District Court, Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Vistagen common stock between April 1, 2024 and December 16, 2025, both dates inclusive (the “Class Period”).Investors have until March 16, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Allegation Details:
According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning its Phase 3 PALISADE-3 trial study of fasedienol, an investigational pherine candidate in development for the acute treatment of social anxiety disorder.On December 17, 2025, Vistagen issued a press release announcing that the PALISADE-3 Phase 3 study of intranasal fasedienol for the acute treatment of social anxiety disorder did not demonstrate a statistically significant improvement on the primary endpoint of change on the Subjective Units of Distress Scale. In pertinent part, defendants announced the trial did not achieve its primary endpoint and there was no treatment difference between fasedienol and placebo for the secondary endpoints.Following this news, the price of Vistagen’s common stock declined dramatically from a closing market of $4.36 per share on December 16, 2025 to $0.86 per share on December 17, 2025, a decline of more than 80%.
Next Steps:
If you purchased or otherwise acquired Vistagen shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apollo Global Management, Inc. (“Apollo” or “the Company”) (NYSE: APO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between May 10, 2021 and February 21, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before May 1, 2026.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Apollo’s leadership team was in regular contact with Jeffrey Epstein about the Company throughout the 2010s. Despite this, the Company claimed that it had never done business with Epstein. The Company’s connection to Epstein could potentially harm its reputation. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Apollo, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
2026-03-05 02:017d ago
2026-03-04 20:197d ago
Nokomis Capital Initiates Stake in Apple Hospitality REIT as Marriott and Hilton Hotels Drive Steady Demand
What happenedAccording to an SEC filing dated February 17, 2026, Nokomis Capital, L.L.C. initiated a new position in Apple Hospitality REIT (APLE +2.09%), reporting ownership of 479,576 shares. The quarter-end reported value for the position also stood at $5.68 million, capturing both the share acquisition and changes in market pricing during the period.
What else to knowThis was a new position, making up 1.35% of Nokomis Capital, L.L.C.’s 13F reportable assets under management as of December 31, 2025
Top holdings after the filing:
NYSEMKT:IAUX: $33.39 million (9.3% of AUM)NYSEMKT:DIA: $25.09 million (7.0% of AUM)NYSE:MGM: $23.66 million (6.6% of AUM)NYSE:HBM: $17.23 million (4.8% of AUM)NYSEMKT:GDX: $17.12 million (4.8% of AUM)As of February 17, 2026, shares were priced at $12.29, down 13.6% over the past year and underperformed the S&P 500 by 24.6 percentage points.
Company overviewMetricValueMarket Capitalization$2.94 billionRevenue (TTM)$1.42 billionNet Income (TTM)175.36 millionDividend Yield7.88%Company snapshotApple Hospitality REIT, Inc. is a leading U.S. hotel real estate investment trust with a diversified portfolio of over 30,000 guest rooms in 87 markets. The company’s strategy centers on upscale, branded hotels that offer operational efficiency and broad customer appeal.
Apple Hospitality REIT targets business and leisure travelers in major metropolitan and regional markets, with a focus on stable, high-traffic locations. It owns and operates a portfolio of 235 upscale, rooms-focused hotels across 34 U.S. states, primarily branded under Marriott, Hilton, and Hyatt.
Apple Hospitality REIT generates revenue through hotel room rentals and related hospitality services, leveraging brand partnerships and geographic diversification to drive occupancy and rate optimization.
What this transaction means for investorsHotel real estate differs from other property types because pricing is reset each night. Unlike apartments or office buildings, which typically have multi-year leases, hotels adjust room rates daily in response to demand. Consequently, for owners such as Apple Hospitality REIT Inc., revenue fluctuates rapidly with changes in travel activity.
The lodging industry experienced a sharp collapse in demand during 2020, followed by a strong recovery led first by leisure travel and later by a gradual return of business trips. That rebound pushed occupancy and room rates higher across much of the sector. As the industry moves further past the recovery phase, performance increasingly depends on whether travel demand can continue to support room pricing rather than simply benefit from reopening momentum.
For investors, the key metric to watch will be revenue per available room (RevPAR), which reflects both occupancy levels and average daily room rates. Apple Hospitality’s portfolio of upscale, rooms-focused hotels affiliated with brands such as Marriott and Hilton benefits from large reservation networks and loyalty programs that help drive consistent demand. Nevertheless, hotel earnings remain closely tied to travel activity, which means future performance will depend on whether room rates and occupancy remain resilient as the travel cycle stabilizes.
2026-03-05 02:017d ago
2026-03-04 20:207d ago
BELLRING INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds BellRing Brands (NYSE: BRBR) Investors to Contact the Firm Regarding Their Rights Before March 23rd
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BellRing (BRBR) To Contact Him Directly To Discuss Their Options
If you purchased or acquired BellRing securities between November 19, 2024 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE:BRBR) in the The United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired BellRing securities between November 19, 2024 and August 4, 2025, both dates inclusive (the “Class Period”).Investors have until March 23, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Allegation Details:
According to the complaint, defendants failed to disclose to investors that its strong sales results did not reflect increased end-consumer demands or brand momentum. Rather, customers accumulated excess inventory as a safeguard against product shortages that had previously constrained BellRing’s supply. Once customers gained confidence that product shortages were a thing of the past, they promptly reduced their inventory by selling through existing products and cutting back on new orders. Following the destocking, the Company admitted that competitive pressures were materially weakening demand.
On August 4, 2025, BellRing reported its fiscal Q3 25 financial results, revealing a disappointing 2025 sales outlook, stating “BellRing management has narrowed its fiscal year 2025 outlook for net sales to [a] range between $2.28-$2.32 billion[.]” On this news, the price of BellRing stock declined $17.46 per share, or nearly 33%, from $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025.
Next Steps:
If you purchased or otherwise acquired BellRing shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
New York, New York--(Newsfile Corp. - March 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Oracle Corporation (NYSE: ORCL) between June 12, 2025, and December 16, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Oracle common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Oracle class action, go to https://rosenlegal.com/submit-form/?case_id=51135 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 6, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Oracle's AI infrastructure strategy would result in massive increases in capital expenditures ("CapEx") without equivalent, near-term growth in revenue; (2) Oracle's substantially increased spending created serious risks involving Oracle's debt and credit rating, free cash flow, and ability to fund its projects, among other concerns; and (3) as a result, defendants' representations about Oracle's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Oracle class action, go to https://rosenlegal.com/submit-form/?case_id=51135 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286312
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-05 02:017d ago
2026-03-04 20:217d ago
Floor & Decor: Still Too Early To Upgrade This To Buy
Floor & Decor remains a hold as macro headwinds and weak comps persist, despite resilient margins. Comparable store sales declined 4.8% in Q4, with monthly cadence worsening and no near-term growth acceleration expected. Unit growth is steady but not accelerating; management plans only 20 new stores in 2026, mirroring 2025 levels.
2026-03-05 02:017d ago
2026-03-04 20:227d ago
Dell Technologies Inc. (DELL) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Lamar Advertising Company (LAMR) Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 6:20 PM EST
Company Participants
Sean Reilly - CEO & President
Conference Call Participants
Cameron McVeigh - Morgan Stanley, Research Division
Presentation
Cameron McVeigh
Morgan Stanley, Research Division
All right. We are on time. So let's get started. And first, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representatives.
And with that, my name is Cameron McVeigh. My pleasure to welcome Sean Reilly to the conference, CEO of Lamar Advertising. Sean?
Sean Reilly
CEO & President
I appreciate you having me.
Question-and-Answer Session
Cameron McVeigh
Morgan Stanley, Research Division
So to start, Sean, you've described the 2026 is having a really good setup. And it sounds like pacings for the rest of the year are promising. The guide if I recall correctly, it's about 3.5% acquisition adjusted growth, 4% AFFO per share growth. I was hoping you could walk us through maybe the building blocks of that guidance and what gives you confidence in the trajectory?
Sean Reilly
CEO & President
Yes. I would say we're basically being conservative with the guidance. Our pacings are stronger than those numbers. National is a real tailwind, and it's been a headwind in the past. And also, I think we're being conservative on our projections for [indiscernible]. It just feels like it's going to be a little stronger than we suggested I feel good.
Cameron McVeigh
Morgan Stanley, Research Division
Great. Good to hear. As you think through 2026 and your outlook for the year, what are the priorities for you, Jay and the team?
Sean Reilly
CEO & President
We got the ERP thing. We got it get done, right? On that
2026-03-05 02:017d ago
2026-03-04 20:267d ago
YieldMax's MSTR Is A Nightmare ETF, Despite Dreamy Dividends
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
MSTY has one of the most eye-catching yields in the ETF universe. But the number that should be keeping investors up at night isn’t the yield, it’s the check size. The most recent weekly distribution was $0.30 per share. At the fund’s peak in late 2024, that number was $4.42. That’s a decline in the income this fund actually delivers, and understanding why it happened is the most important thing any MSTY holder can do right now.
What MSTY Is and Why People Own It YieldMax MSTR Option Income Strategy ETF (NYSEARCA:MSTY) launched in February 2024 with a simple promise: give income investors exposure to the volatility of Strategy (NASDAQ:MSTR) without having to own the stock outright. The fund doesn’t hold MicroStrategy shares directly. Instead, it runs a synthetic options strategy, selling call options on MSTR to collect premium income, while holding roughly 32% of assets in U.S. Treasury notes as collateral. The income those premiums generate gets distributed to shareholders, typically on a weekly basis.
The appeal is obvious. Strategy is one of the most volatile large-cap stocks in the market, essentially a leveraged bitcoin holding company. High volatility means expensive options, and expensive options mean fat premiums for whoever is selling them. For income-hungry investors, that looked like a compelling deal. At its peak, it was delivering extraordinary payouts. The problem is what happened next.
The Core Risk: Your Income Is Borrowed From Your Own Capital MSTY’s primary risk isn’t that Strategy stock might fall, though that matters too. The deeper structural risk is that the fund’s distributions are not purely generated income. When MSTR declines sharply, the options premiums MSTY collects shrink, and the fund’s NAV erodes. As NAV falls, the dollar amount of each distribution falls with it, because the fund can only generate so much premium relative to its shrinking asset base.
The data tells this story clearly. MSTY’s share price has fallen 39.5% over the past year, from $41.82 to $25.29. That price decline tracks closely with what happened to the underlying: Strategy shares dropped 46.8% over the same period, falling from $275.15 to $146.44. As Strategy’s price collapsed, so did the value of the options MSTY was selling — and so did the distributions.
The distribution timeline is stark. In November 2024, the fund paid $4.42 per share. By February 2026, that had fallen to $0.30. The mid-2025 period showed some recovery — $2.37 in May 2025 and $1.18 in July 2025 — but those spikes coincided with the VIX surging to 52.33 in April 2025, an extreme fear event that temporarily inflated options premiums. When volatility normalized, the income collapsed again.
This is the transmission mechanism that matters: Strategy’s price falls, implied volatility spikes briefly but then normalizes, the options MSTY sells become cheaper, distributions shrink, and the lower NAV means each future distribution is drawn from a smaller pool. An investor who bought MSTY expecting $4 monthly checks is now receiving $0.35 per week — and holding a share worth 40% less than a year ago.
The Secondary Risk: Bitcoin Is the Actual Underlying Exposure Owning MSTY means owning, at multiple removes, a bet on bitcoin. Strategy holds 713,502 bitcoins as of February 2026, with a cost basis of approximately $54.26 billion. The company’s quarterly results are dominated by unrealized gains or losses on those holdings — not its software business. In Q4 2025, Strategy reported an unrealized loss of $17.44 billion on digital assets, driving a net loss of $12.44 billion for the quarter.
That bitcoin sensitivity flows directly into MSTY. When bitcoin declines, Strategy’s stock falls. When Strategy’s stock falls, the put options MSTY has written (the short puts that represent some of its largest positions) generate losses, NAV erodes further, and the premiums available on future call sales compress. The fund carries no diversification across underlying equities — its entire options portfolio is concentrated in MSTR calls and puts. There is no hedge against a sustained bitcoin bear market other than the Treasury collateral, which provides income but not capital protection.
Reddit sentiment around Strategy has been predominantly bearish through early 2026, with one widely-circulated post titled “Michael Saylor 3% away from Negative Bitcoin Position” generating 1,000 upvotes and sustained discussion about liquidation risk. That concern may be overstated, but it reflects how the market is pricing the tail risk embedded in Strategy’s balance sheet — and by extension, in MSTY.
What to Monitor Three indicators matter most for MSTY holders:
The VIX and MSTR implied volatility. MSTY’s income depends on expensive options. The VIX currently sits at 23.57, which is elevated relative to the 12-month average of 19.06, temporarily favorable for premium collection. But the December 2025 low of 13.47 shows how quickly that can evaporate. Check the VIX on the Federal Reserve’s FRED database weekly. If VIX drops below 15 and stays there, MSTY’s distributions will compress further. Bitcoin’s price trend. Because Strategy’s stock price moves with bitcoin, bitcoin’s direction is the most upstream signal for MSTY’s NAV trajectory. A sustained decline below Strategy’s average cost basis of approximately $76,000 per coin would create acute pressure on the stock and on MSTY’s options structure. Monitor bitcoin prices daily through any major exchange or financial data site. Weekly distribution amounts. YieldMax publishes distribution announcements before each ex-dividend date. The trajectory of those weekly payments is the most direct real-time signal of how the strategy is performing. A sustained move below $0.25 per week at the current NAV would indicate the premium environment has deteriorated further. Compare each distribution to the prior four weeks, not just the prior period, to identify trend direction. What Staying in MSTY Actually Requires You to Believe MSTY is a fund where the headline yield can be deeply misleading. The 99 basis point expense ratio is the least of an investor’s concerns. The real cost is NAV erosion that has outpaced distributions during sustained drawdowns in Strategy’s stock. An investor who bought MSTY near its inception and held through today has received meaningful income, but has also watched the share price fall from $14.63 at launch to $25.29 today, a gain that looks reasonable until you factor in that the 2024 peak price was substantially higher and distributions have shrunk from their peak.
The fund is not broken in a structural sense. It does what it says: it sells options on Strategy and distributes the premiums. The risk is that what it does is inherently tied to a single, bitcoin-correlated stock in a way that makes income both volatile and potentially self-defeating during prolonged downturns. If bitcoin recovers and Strategy’s stock climbs back toward its 2024 highs, MSTY’s distributions could recover meaningfully. If bitcoin enters another extended bear cycle, the current $0.30 weekly payout could shrink further as NAV continues to erode. That asymmetry is what should keep MSTY holders watching closely.
2026-03-05 02:017d ago
2026-03-04 20:277d ago
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”), of the important April 20, 2026 lead plaintiff deadline.
SO WHAT: If you purchased NuScale Class A common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the NuScale class action, go to https://rosenlegal.com/submit-form/?case_id=19967 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) ENTRA1 Energy LLC (“ENTRA1”) had never built, financed, or operated any significant projects– let alone projects in the highly technical and complicated field of nuclear power generation during its entire operating history; (2) NuScale had entrusted its commercialization, distribution, and deployment of its NuScale Power Module (“NPMs”) and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (3) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; and (4) as a result, NuScale’s commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the NuScale class action, go to https://rosenlegal.com/submit-form/?case_id=19967 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
2026-03-05 02:017d ago
2026-03-04 20:307d ago
European Wax Center (EWCZ) Reports Q4 Earnings: What Key Metrics Have to Say
European Wax Center, Inc. (EWCZ - Free Report) reported $45.1 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 9.3%. EPS of $0.10 for the same period compares to $0.16 a year ago.
The reported revenue represents a surprise of -0.88% over the Zacks Consensus Estimate of $45.51 million. With the consensus EPS estimate being $0.04, the EPS surprise was +130.95%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how European Wax Center performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
System-wide sales: $225.6 million versus the three-analyst average estimate of $223.24 million.Ending center count: 1,047 versus the two-analyst average estimate of 1,047.Revenue- Marketing fees: $7.22 million versus the three-analyst average estimate of $7.02 million. The reported number represents a year-over-year change of -1.5%.Revenue- Royalty fees: $12.51 million versus the three-analyst average estimate of $11.99 million. The reported number represents a year-over-year change of -2.1%.Revenue- Product sales: $22.57 million versus $24.16 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -14.3% change.Revenue- Other revenue: $2.8 million versus $2.93 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -14.7% change.View all Key Company Metrics for European Wax Center here>>>
Shares of European Wax Center have returned +46.1% over the past month versus the Zacks S&P 500 composite's -1.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
2026-03-05 02:017d ago
2026-03-04 20:327d ago
Box, Inc. (BOX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Q4: 2026-03-03 Earnings SummaryEPS of $0.49 beats by $0.15
|
Revenue of
$305.88M
(9.43% Y/Y)
beats by $234.66K
Box, Inc. (BOX) Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 5:35 PM EST
Company Participants
Aaron Levie - Co-Founder, CEO & Director
Dylan Smith - Co-Founder & CFO
Conference Call Participants
Josh Baer - Morgan Stanley, Research Division
Presentation
Josh Baer
Morgan Stanley, Research Division
All right. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. My name is Josh Baer, software analyst here at Morgan Stanley, and we have the Box Co-founders and senior leadership team with us today, CEO, Aaron Levie; and CFO, Dylan Smith. Thank you so much for joining us.
Aaron Levie
Co-Founder, CEO & Director
Thank you. Good to be here.
Question-and-Answer Session
Josh Baer
Morgan Stanley, Research Division
Let's start off a review of earnings last night. You reported really strong earnings. You guided to a growth acceleration in constant currency. Aaron, maybe starting with you, if you could cover some of the business momentum from a strategic or a competitive or technology perspective. And then, Dylan, if you could follow up with some of the most important financial takeaways.
Aaron Levie
Co-Founder, CEO & Director
Yes. So there's sort of 2 things happening, and I'll sort of frame the connective tissue. The first is that enterprises, I think, have always wanted to really tap into the kind of underlying data that they have inside their organization. This is sort of this ongoing thing that I think we've always felt as an organization. So you have all these contracts, you have marketing assets, you have research materials, you have financial documents.
And you've sort of -- every enterprise has sat around saying we have all this data, but we've never really
2026-03-05 02:017d ago
2026-03-04 20:327d ago
Cricut, Inc. (CRCT) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Q4: 2026-03-03 Earnings SummaryEPS of $0.04 beats by $0.01
|
Revenue of
$203.60M
(-2.73% Y/Y)
beats by $3.65M
Cricut, Inc. (CRCT) Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 6:20 PM EST
Company Participants
Jim Suva - Senior Vice President of Finance, Treasurer & Investor Relations
Kimball Shill - Chief Financial Officer
Conference Call Participants
Erik Woodring - Morgan Stanley, Research Division
Presentation
Erik Woodring
Morgan Stanley, Research Division
Good afternoon, guys, day 3 of the Morgan Stanley TMT Conference. I appreciate you guys joining us. My name is Erik Woodring. I lead the U.S. IT hardware coverage here.
I'm pleased to be joined by Cricut, Kimball Shill, CFO; Jim Suva, Treasurer, SVP of Finance and IR. Welcome to the conference guys. Thank you for joining us.
Before we get started, we got to do this little disclaimer. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. And then Jim from your side, please?
Jim Suva
Senior Vice President of Finance, Treasurer & Investor Relations
And I would refer you to the Cricut Investor Relations website where we have our safe harbor statements, and I refer you to our most recently published 10-Q and 10-K for our risks and uncertainty statements. And with that, Erik, let's get things going.
Question-and-Answer Session
Erik Woodring
Morgan Stanley, Research Division
Perfect. Let's get going. So first of all, thank you guys for joining us. A lot to talk about quick turnover from last night where you reported earnings, and that's probably the best place to start for us. So I imagine a lot of people listening were here at the conference. Can you maybe just touch on the most important and salient points from the report last night and help the audience better understand the high-level message for 2026?
Evertz Technologies Limited (ET:CA) Q3 2026 Earnings Call March 4, 2026 5:00 PM EST
Company Participants
Brian Campbell - Executive Vice-President of Business Development
Doug Moore - CFO & Secretary
Conference Call Participants
Thanos Moschopoulos - BMO Capital Markets Equity Research
Robert Young - Canaccord Genuity Corp., Research Division
Paul Treiber - RBC Capital Markets, Research Division
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Evertz Q3 Investor Conference Call. [Operator Instructions] This call is being recorded on Wednesday, March 4, 2026.
I would now like to turn the conference over to Brian Campbell, Executive VP of Business Development. Please go ahead, sir.
Brian Campbell
Executive Vice-President of Business Development
Thank you, John. Good afternoon, everyone, and welcome to Evertz Technologies conference call for our fiscal 2026 third quarter ended January 31, 2026, with Doug Moore, Evertz' Chief Financial Officer; and myself, Brian Campbell. Please note that our financial press release and MD&A will be available on SEDAR and on the company investor website. Doug and I will comment on the financial results and then open the call to your questions.
Turning now to Evertz' results. I'll begin by providing a few highlights, and then Doug will provide additional detail. First off, sales for the third quarter totaled a record $139.3 million, up 5% sequentially from the prior quarter. This includes revenue in the international region of $43.7 million, up 27.7% sequentially. Recurring software, services, and other software revenue increased 12.3% year-over-year, totaling $62.5 million in the quarter.
Our sales base is well diversified with the top 10 customers accounting for approximately 44% of sales during the quarter, with no single customer accounting for more than 16% of sales. In fact, we had 107 customer orders of over $200,000. Gross margin in the quarter was $81.2 million, or 58.3% compared to 57.8% in the third quarter of the prior
2026-03-05 02:017d ago
2026-03-04 20:337d ago
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PayPal Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PYPL
New York, New York--(Newsfile Corp. - March 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PayPal Holdings, Inc. (NASDAQ: PYPL) between February 25, 2025 and February 2, 2026, inclusive (the "Class Period"), of the important April 20, 2026 lead plaintiff deadline.
SO WHAT: If you purchased PayPal common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the PayPal class action, go to https://rosenlegal.com/submit-form/?case_id=53653 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants provided investors with material information concerning PayPal's expected financial targets for 2027 alongside the growth trajectory for its core branded checkout segment ("Branded Checkout"). Defendants' statements included, among other things, confidence in PayPal's ability to capitalize on its growth potential through new initiatives to facilitate Branded Checkout growth both in the U.S. and internationally. According to the lawsuit, defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of PayPal's salesforce; notably, that it was not truly equipped to execute on PayPal's perceived growth potential and were "too optimistic" as to how easily and expeditiously its staff could change customer adoption. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the PayPal class action, go to https://rosenlegal.com/submit-form/?case_id=53653 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286316
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-05 02:017d ago
2026-03-04 20:457d ago
Broadcom CEO Hock Tan sees AI chip revenue 'significantly' above $100 billion next year
Broadcom CEO Hock Tan sees the artificial intelligence boom gaining so much steam that he's projecting AI chip revenue next year "significantly in excess of $100 billion."
After the chipmaker reported better-than-expected results for the fiscal first quarter and issued a strong forecast for the current period, Tan said on his company's earnings call that demand is picking up from large customers that are increasingly in need of Broadcom's help in designing custom silicon.
"We have also secured the supply chain required to achieve this," Tan said, regarding the 2027 sales target.
AI revenue in the first quarter more than doubled from a year earlier to $8.4 billion, while total sales increased 29% to $19.3 billion. The company expects AI semiconductor revenue of $10.2 billion this quarter.
Broadcom shares popped more than 5% in extended trading on Thursday after Tan's comments.
Chip companies like Broadcom have faced a number of headwinds in recent months, including a shortage of the high bandwidth memory crucial for custom accelerators, and capacity constraints at the most advanced levels of chip manufacturing and packaging.
Broadcom helps its customers translate their chip designs into silicon, providing back-end support before the processors are sent off to be manufactured at huge fabrication plants by companies like Taiwan Semiconductor Manufacturing Company.
watch now
It's a role that's fueled Broadcom's growth as more tech giants design in-house accelerators for AI. Tan said custom AI deployment is entering its "next phase" and is expected to speed up, as the company helps six key customers design their chips. Chief among those are Google, Meta, Anthropic and OpenAI, with Fujitsu and ByteDance likely as the final two.
Google was the first to the in-house chip game in 2015, with its tensor processing units designed alongside Broadcom. Google has made its chips available to cloud customers since 2018, with key customers now including Apple and Anthropic. Broadcom expects even stronger demand from next-generation Google chips in 2027.
Meta is also reportedly in talks to use Google's TPUs, and Broadcom assists the social media company with developing its own MTIA accelerator. Analysts have cast doubt on the future of Meta's custom silicon program, but the "MTIA roadmap is alive and well," Tan said on the earnings call.
During the question and answer portion of the call, Bernstein Research analyst Stacy Rasgon pushed Tan on the specific sources of the projected $100 billion in AI chip revenue. He counted 3 gigawatts of capacity at Anthropic, 3 gigawatts at Google, at least 2 gigawatts with Meta, and 1 gigawatt from OpenAI, among others. Tan said the dollars per gigawatt "vary, sometimes quite dramatically," but that his estimates were "not far" off.
While Tan said that the AI revenue boost would come from "just chips," Broadcom makes much more than just AI accelerators. Ben Bajarin of Creative Strategies said it includes digital signal processors, data processing units and networking switches.
It's "everything in that bucket," Bajarin said.
— CNBC's Jordan Novet contributed to this report.
watch now
2026-03-05 02:017d ago
2026-03-04 20:527d ago
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Lakeland Industries, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LAKE
WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Lakeland Industries, Inc. (NASDAQ: LAKE) between December 1, 2023 and December 9, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 24, 2026.
SO WHAT: If you purchased Lakeland securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Lakeland class action, go to https://rosenlegal.com/submit-form/?case_id=50020 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Lakeland was experiencing significant, sustained issues with its Pacific Helmets and Jolly businesses, including, inter alia, shipping-related delays, production issues, and slower than expected rollout of new products; (2) accordingly, defendants overstated the anticipated and actual positive impact of these businesses on Lakeland’s financial results, as well as the overall strength and quality of Pacific Helmets’ and Jolly’s respective operations; (3) Lakeland’s business and financial results were significantly deteriorating because of, inter alia, tariff-related headwinds and timing, certification delays, and material flow issues in its acquired businesses; (4) accordingly, defendants overstated the strength of their tariff mitigation measures and “small, strategic, and quick” (“SSQ”) M&A strategy; (5) as a result of all the foregoing issues, defendants’ financial guidance was unreliable; and (6) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Lakeland class action, go to https://rosenlegal.com/submit-form/?case_id=50020 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
Kits Eyecare Ltd. (KITS:CA) Q4 2025 Earnings Call March 4, 2026 4:30 PM EST
Company Participants
Roger Hardy - Co-Founder, CEO & Chairman of the Board
Joseph Thompson - Co-Founder & COO
Zhe Choo - Chief Financial Officer
Conference Call Participants
Gianluca Tucci - Haywood Securities Inc., Research Division
Martin Landry - Stifel Nicolaus Canada Inc., Research Division
Luke Hannan - Canaccord Genuity Corp., Research Division
Matt Koranda - ROTH Capital Partners, LLC, Research Division
Doug Cooper - Beacon Securities Limited, Research Division
Frederic Tremblay - Desjardins Securities Inc., Research Division
Presentation
Operator
Good morning, and welcome to the Kits Eyecare Fourth Quarter 2025 Financial Results Conference Call. This call is being recorded and available later today for replay. Your hosts today are Roger Hardy, Chief Executive Officer; Joseph Thompson, Chief Operating Officer; and Zhe Choo, Chief Financial Officer.
Before we begin, I'm required to provide the following statement respecting forward-looking information, which is made on behalf of Kits and all of its representatives on this call. Certain statements made on this call will contain forward-looking information. These forward-looking statements generally can be identified with the use of words such as intend, believe, could, expect, estimate, forecast, may, would and other words of similar meaning. This forward-looking information is based on management's opinions, estimates and assumptions in light of the experience and perception of historical trends, current conditions and expected future developments as well as factors that they currently believe are appropriate and reasonable in the circumstances.
Actual results could differ materially from a conclusion, forecasts, expectation, belief or projections in the forward-looking information, and certain material factors and assumptions were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information. Management cautions investors not to rely on forward-looking information.
Additional information about the material factors that could
3D-printed oil pump jacks, Iranian flag, and a rising stock graph appear in this illustration taken March 2, 2026. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
TOKYO, March 5 (Reuters) - Oil prices rose on Thursday amid growing concern over the prolonged closure of the Strait of Hormuz, as the U.S.-Iran war chokes off vital Middle East oil and gas flows while production facilities limit output.
Brent crude was trading up $1.67, or 2.05%, at $83.07 per barrel by 0141 GMT. U.S. West Texas Intermediate crude rose $1.94, or 2.60%, to $76.60.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
The U.S.–Iran war widened on Wednesday after a U.S. strike hit an Iranian warship off Sri Lanka and U.S. Senate Republicans backed President Donald Trump's military campaign against Iran.
They voted against a bipartisan resolution aiming to stop the air war and require Congress to authorise hostilities against Iran.
Iraq, the second-largest crude producer in the Organization of the Petroleum Exporting Countries, has cut output by nearly 1.5 million barrels a day for lack of storage and an export route, officials told Reuters.
Qatar, the biggest liquefied natural gas producer in the Gulf, declared force majeure on gas exports on Wednesday, with sources saying a return to normal production volumes may take at least a month.
Shipping via the Strait of Hormuz, a key conduit for nearly a fifth of global energy consumption, has ground to a near-halt for the fifth day during the war on Iran and Tehran's retaliation.
Britain's maritime trade operations agency reported a large explosion heard and seen by the master of a tanker anchored 30 nautical miles southeast of Kuwait's Mubarak Al Kabeer, with a small craft later seen leaving the area.
Iran has refrained from targeting most critical energy infrastructure while keeping shipping risk extremely elevated, J.P. Morgan said in a client note, estimating that about 329 oil vessels are stuck in the Gulf.
"Storage capacity in the Gulf Cooperation Council countries and prevailing energy prices are limiting factors on the length of the U.S. campaign," it added.
The reference was to the political and economic alliance of Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Oman and Bahrain.
Most of the oil fields can restart within days, with full capacity typically restored within two to three weeks, J.P. Morgan said.
"While operators must gradually rebuild reservoir pressure, particularly in Iraq, where water injection is critical, the primary constraint today is logistics rather than geology."
Reporting by Katya Golubkova in Tokyo; Editing by Chris Reese and Clarence Fernandez
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-03-05 01:017d ago
2026-03-04 17:197d ago
Beyond DeFi: Buterin Urges Ethereum to Build ‘Sanctuary Tech' Against Digital Control
Vitalik Buterin frames “sanctuary tech” as digital islands that are resilient to political and corporate pressure.
Vitalik Buterin has proposed positioning Ethereum as part of a larger “sanctuary technologies” ecosystem.
He described these as free and open-source tools that allow people to live, work, communicate, and collaborate in ways that are resilient to outside pressures.
Buterin’s Vision The Ethereum co-founder outlined in a social media post that the goal is to create digital islands of stability, reduce the stakes of power struggles, and interdependence that cannot be weaponized. This is in response to concerns brought to him over the past year about growing government control and surveillance, wars, increasing corporate power, the decline in quality across major technology platforms, social media turning into a memetic battleground, and the rise of AI and how it interacts with these forces.
Buterin also shared that people feel like Ethereum has not meaningfully improved the lives of people facing these pressures in areas the community cares about, such as freedom, privacy, digital security, and community self-organization.
In response, he has proposed sanctuary technologies as a practical solution to the situation. Instead of trying to dominate existing systems, these tools would allow individuals and institutions to operate in ways that are not vulnerable to outside pressure. In this vision, Ethereum would contribute by providing a shared digital space without an owner, where people can coordinate and build lasting social and economic structures.
However, he clarified that this approach is not about remaking the world in the network’s image, nor is it going to force all finance onto blockchains or move all governance into decentralized structures.
Instead, Buterin described the aim as “de-totalization,” which means reducing the risk that any winner in a global power struggle gains total control over others while also lessening the chance that any loser faces total defeat.
You may also like: $1 Billion Floods Back Into Crypto Funds, Snapping Five-Week $4B Bleed Buterin Says Ethereum’s Biggest Bottlenecks Are State Tree and VM, Proposes Deep Fix Vitalik Buterin Unveils Ethereum’s Comprehensive Quantum Resistance Roadmap Ethereum’s Limitations The post also addressed the idea that Ethereum should focus only on finance. As much as Buterin acknowledged that financial freedom is important, he said it alone cannot solve broader issues like power, surveillance, and social fragmentation.
He added that the chain cannot fix the world on its own, and that trying to do so would require a level of centralized power that contradicts the principles of a decentralized community. Its strength lies in enabling persistent digital structures, which form the basis of his idea for sanctuary technologies.
The Ethereum co-founder gave examples of what he sees as liberating technologies, including Starlink, locally running open-weight large language models, Signal, and Community Notes.
He concluded by calling for clarity and coordination across the full technology stack, from wallets and applications to operating systems and hardware, while focusing on users who genuinely need sanctuary technologies and working with allies inside and outside the crypto sector.
Tags:
2026-03-05 01:017d ago
2026-03-04 17:227d ago
Hyperliquid and DEXs Storm the Top 10 — Is the CEX Era Fading?
Decentralized exchanges surpass 10% market share in both spot and perpetual trading, narrowing the gap with centralized platforms. Hyperliquid enters the Top 10 derivatives exchanges by volume, marking a breakthrough for on-chain infrastructure. Meanwhile, Uniswap and PancakeSwap rank among leading spot venues, reinforcing the structural shift toward decentralized liquidity.
Hyperliquid and DEXs are reshaping exchange rankings as on-chain platforms climb into the Top 10 by trading volume. While centralized exchanges continue to lead global liquidity, fresh data shows decentralized competitors expanding at a steady pace across spot and derivatives markets.
Hyperliquid And DEXs Expand Market Share In Spot And Perpetuals Recent industry reports indicate that centralized venues processed nearly $80 trillion in combined spot and perpetual volume during 2025. That figure confirms their scale. However, decentralized exchanges doubled their spot market share over the past two years, rising from 6.9% in early 2024 to 13.6% at the start of 2026.
Monthly DEX spot volume climbed from about $96 billion to more than $231 billion over the same period. At one point in mid-2025, DEXs captured 24.5% of total spot activity, driven in part by routing mechanisms that directed additional flow on-chain. Even after that peak cooled, DEX market share remained above 10%, suggesting structural adoption rather than a temporary spike.
In derivatives, the shift proved even more visible. The perpetual futures market expanded 75% in two years, reaching $7.24 trillion in monthly volume by January 2026. Within that growth, decentralized platforms increased their share from 2.0% to 10.2%. Roughly one in every ten dollars traded in crypto perpetuals now moves through smart contracts instead of centralized order books.
Security, Listings, And The Structural Divide Hyperliquid emerged as a central player in this transition. Between August 2025 and January 2026, the platform recorded $1.59 trillion in cumulative perpetual volume, becoming the only DEX ranked among the Top 10 derivatives exchanges. On the spot side, Uniswap and PancakeSwap each surpassed $0.5 trillion in six-month trading activity, placing them alongside established centralized brands.
Token listings highlight a deeper contrast. Large centralized platforms listed around 1,200 tokens over 13 months, averaging fewer than 100 new assets per month. In contrast, permissionless protocols enabled millions of tokens to launch and trade without prior approval, reflecting the open architecture of decentralized finance.
Security remains a shared challenge. The industry recorded more than $2.4 billion in exchange-related losses over the past year, with centralized venues accounting for the majority. Decentralized exploits occurred as well, often linked to smart contract vulnerabilities, yet overall losses were smaller in aggregate terms.
2026-03-05 01:017d ago
2026-03-04 17:277d ago
Dogecoin Price Outlook as BTC Recovers Above $73,000
Dogecoin price recorded a strong rally on Thursday as the broader cryptocurrency market recovered with Bitcoin’s climb above $73,000. The meme coin attracted renewed investor interest during the latest market rebound. Dogecoin gained nearly 15% within the last 24 hours as buying momentum strengthened.
Ethereum also trailed behind the trend and rose by about 8% in the same period. The larger crypto market exhibited a definite recovery following a few days of uncertainty. The total cryptocurrency market capitalization grew by 6% in 24 hours, to reach 2.49 trillion.
Here’s Why Dogecoin Price is Up Today Dogecoin emerged as the top performer among the largest digital assets during the market rebound. The token outperformed Bitcoin and many other major cryptocurrencies during the latest rally.
The market sentiment was improved, leading to a large trading activity around Dogecoin. Data indicate that Dogecoin made a surge with 24 hours trading volume of $2.39 billion. The rise is a growth of 78% in trading action.
The same period also resulted in a fresh impetus in the meme coin sector. Top meme coins, like PEPE, SHIB, BONK, and PUMP had observed increases in addition to Dogecoin. The total meme coin market capitalization reached $35.2 billion following a 5% increase of 5%.
The market sentiment improved as investors are reacting positively to the macroeconomic developments and softening geopolitical issues. News of potential talks with Iran also helped to boost the risk asset prospects.
Reports show that the Ministry of Intelligence of Iran expressed readiness to negotiate conditions that have the potential to ease of the tension between the United States and Israel. The progress enabled the increase of the investor confidence within the global financial markets, including cryptocurrencies.
ETF inflows strengthen crypto market sentiment Institutional investment activity continues to influence sentiment across the digital asset market. Dogecoin remains among the few crypto assets associated with spot exchange-traded fund products in the United States.
According to SoSoValue, on March 3rd (ET), the total net inflow for Bitcoin spot ETFs was $225 million, with BlackRock’s ETF IBIT leading the inflow at $322 million. Ethereum spot ETFs saw a total net outflow of $10.75 million, while BlackRock’s ETF ETHA led the inflow with… pic.twitter.com/QblTSy2T4b
— Wu Blockchain (@WuBlockchain) March 4, 2026
Bitwise and Grayscale asset managers had previously received the approval of the U.S. Securities and Exchange Commission regarding related products. Data on the flow of funds show that institutions are still interested in investing in Bitcoin products.
The total net inflows into Bitcoin spot ETFs reached up to 225 million on March 3. BlackRock IBIT ETF recorded the largest inflows of approximately 322 million dollars in the fund.
DOGE Price Rallies Above $0.10 as Bullish Momentum Target $0.15 As of the reporting time, the DOGE price soared to $0.102 over the past 24 hours.
The four-hour chart indicates that the buyers have driven the price beyond the critical $0.10 support. The momentum signals indicate that the bullish influence is growing following several periods of lateral consolidation.
The Relative Strength Index rose to around 70, which indicated increasing demand but got close to short-term overbought. Meanwhile, the Chaikin Money Flow is in the positive realm, which means that the capital inflow in Dogecoin is stable.
The nearest resistance can be observed at $0.12, where the price has been unable to sustain the upward trend. A confirmed break above this zone could open the path toward the $0.13 technical target as per the detailed Dogecoin price analysis.
Source: DOGE/USDT 4-hour chart: Tradingview If bullish pressure intensifies, analysts watch a secondary upside target around $0.15. However, failure to hold above $0.10 may trigger a short pullback toward $0.095 support.
2026-03-05 01:017d ago
2026-03-04 17:357d ago
Crypto Price Prediction Today 4 March – XRP, Bitcoin, Ethereum
We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More
Ad Disclosure
Ad Disclosure
We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More
Tim Hakki
Web 3 Journalist
Tim Hakki
Part of the Team Since
Feb 2024
About Author
A journalist and copywriter with a decade's experience across music, video games, finance and tech.
Has Also Written
Ad Disclosure
Ad Disclosure
We believe in full transparency with our readers. Some of our content includes affiliate links, and we may earn a commission through these partnerships. However, this potential compensation never influences our analysis, opinions, or reviews. Our editorial content is created independently of our marketing partnerships, and our ratings are based solely on our established evaluation criteria. Read More
Last updated:
March 4, 2026
The price of Bitcoin is soaring near $71,500 despite war between the U.S. and Iran, signaling that crypto markets may have priced it in already.
At the same time, traders are expecting the eventual passage of the U.S. CLARITY Act to trigger the next wave of growth across digital assets.
When that happens, the three biggest cryptocurrencies stand to gain the most…
Discover: The best meme coins in the world right now.
XRP (XRP): Ripple’s Stablecoin, Tokenization and Payments Crypto Could Hit $5XRP ($XRP) commands a market capitalization of $86 billion, making it the leading blockchain solution for cross-border payments.
Ripple engineered the XRP Ledger (XRPL) for near-instant settlement and ultra-low fees, presenting a modern alternative to the expensive and slow SWIFT.
Ripple recently doubled down on transforming XRPL into core infrastructure for stablecoins and tokenized real-world assets, while preserving XRP’s role as the network’s primary liquidity mechanism.
Both the UN Capital Development Fund and the White House have hailed the potential of Ripple’s technology to modernize global payment rails.
Adding to the bullish narrative, the approval of spot XRP exchange-traded funds (ETFs) in the U.S. has expanded access for both institutional and retail participants.
On the charts, XRP could be breakout out of a bullish flag formation, which under supportive macro and industry conditions, could see prices hitting $5 in H1.
Bitcoin (BTC): Can the Crypto Pioneer Set a New Price Record by Summer?Bitcoin ($BTC), the world’s largest cryptocurrency by market value, previously surged to a record high of $126,080 on October 6.
That rally was followed by a sharp pullback, fueled by geopolitical uncertainty and speculation around potential U.S. military actions involving Iran and Greenland.
The resulting sell-off erased nearly half of BTC’s value, briefly dragging prices to $63,000 last weekend.
Despite the volatility, Bitcoin’s status as “digital gold” continues to attract investors seeking protection from inflation, currency debasement, and broader macroeconomic instability.
Growing institutional adoption, lower post-halving supply, and expectations for clearer U.S. regulatory guidance could help restore upside momentum soon.
In addition, if Donald Trump delivers his promise for a U.S. Strategic Bitcoin Reserve, Bitcoin’s dominance in the digital asset landscape could be reinforced for years.
Ethereum (ETH): The Backbone of DeFi Eyes New HighsEthereum ($ETH) underpins much of decentralized finance and carries a market capitalization close to $249 billion.
The network currently secures roughly $53 billion TVL, making it the most active ecosystem for on-chain financial activity.
If market sentiment improves, ETH could revisit the $5,000 resistance zone as early as June, potentially eclipsing its previous all-time high of $4,946 set last August.
Over the longer term, Ethereum’s trajectory toward five-figure prices hinges on regulatory clarity in the U.S. and favorable macroeconomics. Passage of CLARITY could accelerate institutional adoption of stablecoins and tokenized real-world assets built on Ethereum.
Technically, ETH is attempting to break free from a bearish pennant pattern that developed throughout February. For long-term holders, current price levels may offer a strategic accumulation window.
Bitcoin Hyper: A Low Price Crypto Presale Bringing Solana-Speed Performance to BitcoinWhile Bitcoin, XRP, and Ethereum present strong long-term cases, history suggests the most explosive gains often come from early-stage exposure to new crypto infrastructure plays.
Bitcoin Hyper ($HYPER) extends Bitcoin’s functionality by integrating Solana’s speed and efficiency through a Layer 2 scaling solution. The design reduces transaction fees while retaining Bitcoin’s core security framework.
Through Bitcoin Hyper, users can stake assets, generate yield, trade tokens, and interact with smart contracts without moving funds off the Bitcoin network.
The project has already raised $31.8 million in its ongoing presale, drawing increasing interest from major investors and exchange platforms. As a result, $HYPER is emerging as one of the most closely watched crypto launches of the year.
Those looking to secure $HYPER at its fixed presale price can visit the official Bitcoin Hyper website and connect a supported wallet such as Best Wallet.
Purchases are also available via bank card.
Visit the Official Website Here
2026-03-05 01:017d ago
2026-03-04 17:377d ago
Tether commits $50M to Eight Sleep at $1.5B for on-device AI
Tether invests $50M in Eight Sleep, accelerating on-device AI health technologyTether Investments has made a $50 million strategic investment in Eight Sleep at a $1.5 billion valuation to advance localized, on-device AI health technology, according to Tether Investments (https://tether.io/news/tether-makes-strategic-investment-in-eight-sleep-at-1-5b-to-accelerate-sustainable-health-intelligence/). The deal focuses on accelerating health intelligence that runs on consumer hardware rather than the cloud.
Eight Sleep, a New York City–based developer of advanced sleep technology and AI-powered health systems, is the recipient of the funding, as reported by Finsmes (https://www.finsmes.com/2026/03/eight-sleep-receives-strategic-investment-from-tether-investments.html). The partnership frames on-device processing as a way to deliver faster insights while limiting data movement.
Why Eight Sleep’s $1.5B valuation matters for Tether partnershipThe $1.5 billion valuation sets expectations for execution. It places emphasis on converting sleep data into broader preventive health insights, scaling a hardware-plus-software model, and progressing toward clinical-grade features.
Eight Sleep reportedly reached free-cash-flow positivity in 2025, a rarity for consumer hardware businesses, as reported by TechCrunch (https://techcrunch.com/2026/03/04/eight-sleep-raises-50m-at-1-5b-valuation/). That financial footing could help sustain investment in regulated features and international operations.
Leadership has positioned the move as expanding beyond sleep-specific use cases. “Sleep was just the beginning… this partnership gives us the infrastructure to take that intelligence into every aspect of personal health,” said Matteo Franceschetti, co-founder and CEO of Eight Sleep.
BingX: a trusted exchange delivering real advantages for traders at every level.
In the near term, the collaboration is described as expanding AI-driven health technology within existing products rather than relying solely on cloud services, as reported by The Block (https://www.theblock.co/post/392213/tether-invests-eight-sleep-at-1-5-billion-valuation). Enhancements to on-device models could surface new insights while preserving responsiveness on the Pod platform.
Because edge inference reduces remote data transfer, privacy risks tied to continuous uploads may be lower than cloud-only designs. Any prospective clinical features will require clear consent flows and governance to maintain trust.
What to watch next for Tether and Eight SleepRegulatory and clinical validation milestones for AI health featuresClinical validation will be decisive. Pursuit of regulatory clearance for features such as sleep apnea detection would shift Eight Sleep from wellness toward medical territory, influencing claims, labeling, and regional market access.
Business model signals: subscriptions, international rollout, free cash flowKey signals include subscription adoption, churn, returns, and sustained free cash flow. Expansion pacing and regulatory scope will shape unit economics across regions.
FAQ about Tether investment in Eight SleepHow does Eight Sleep’s $1.5B valuation compare to its previous rounds and to peers in sleep and health tech?Step-up from a reported $1B round about eight months earlier, as noted by AIVest; peer comps vary widely across sleep and health tech due to scope and regulation.
Will Eight Sleep pursue FDA clearance for sleep apnea or other clinical features, and what is the expected timeline?Eight Sleep targets medical applications, including sleep apnea; any clearance would depend on FDA review. No formal timeline has been disclosed, according to Yahoo Finance’s 2025 funding coverage.
DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.
Rate this post
2026-03-05 01:017d ago
2026-03-04 17:407d ago
Gate Ventures Backs Sats Terminal as Bitcoin Lending Tools Expand
Gate Ventures, the venture capital arm of Gate.com, has made a strategic investment in Bitcoin finance platform Sats Terminal, a startup building tools that let users borrow, swap, and generate yield with bitcoin while keeping custody of their coins.
2026-03-05 01:017d ago
2026-03-04 17:507d ago
Bitcoin Outpaces Gold and Oil Amid Early Days of US–Iran Conflict
Bitcoin rose 12.1% since the U.S. and Israel launched airstrikes against Iran on February 28, outperforming gold and oil. Crude oil climbed 10.4% amid the closure of the Strait of Hormuz, while gold fell 3% and silver posted losses of 10.2%. A study with 9,072 experiments across 36 AI models found that agents choose Bitcoin 48% of the time as the optimal monetary asset. Four days after the start of the American and Israeli airstrikes against Iran, Bitcoin proved to be the best-performing asset among the major global investment classes.
Since Donald Trump authorized Operation Epic Fury at 1:15 a.m. on February 28, New York time, Bitcoin climbed 12.1%, rising from $65,492 to $73,231 at the time of writing. The S&P 500 barely moved, with a change of just -0.1%, while Nvidia posted a modest recovery of 2.8%, a figure that still fell short of matching the performance of the world’s largest cryptocurrency.
Gold, historically considered the ultimate safe haven in wartime contexts, posted a 3% decline after an initial peak it could not sustain. Silver fully erased its brief initial rally and accumulated losses of 10.2%. The appreciation of the dollar and the shift of geopolitical fear toward inflation expectations partly explained the reversal in precious metals.
The Strait of Hormuz and the Logic of the Barrel Crude oil climbed 10.4%, driven by the effective closure of the Strait of Hormuz, the strategic corridor through which approximately one fifth of the world’s daily supply flows. Tanker traffic in the area fell by around 81% since the conflict began, after insurers withdrew war risk coverage. Freight rates in the area reached historic highs. Brent touched $82 per barrel at its initial peak, and analysts at Barclays warned that the price could reach $100 if the blockade holds. OPEC+ announced an additional output of 206,000 barrels per day to cushion the impact, though the effect was only partial.
Bitcoin as a Crisis Asset Beyond the wartime context, a recent study provided an additional perspective on Bitcoin’s role in the global financial ecosystem. Researchers published the results of 9,072 experiments conducted across 36 frontier artificial intelligence models. AI agents chose Bitcoin 48% of the time when selecting an optimal monetary asset. In store-of-value scenarios specifically, 79% opted for Bitcoin. Claude Opus 4.5, by Anthropic, one of the most widely used models in the world, chose it in 91% of cases.
It is worth noting that, in terms of year-to-date accumulation, the picture is different: BTC is down 16%, while gold rose 18% over the same period.